Among the most clinically relevant molecular aberrations in AML, internal tandem duplications in the FMS‐like tyrosine kinase 3 gene (FLT3‐ITD) are found in approximately 30% of cytogenetically normal AML cases [2]. Here, FLT3 is linked to acute myeloid leukemia.